Tag Archives: DOE

Obviousness = Equivalence? Saint-Gobain v. Siemens

Posted on October 14, 2011 by Warren Woessner

Saint-Gobain Ceramics (“S-G”) has asked the Supreme Court to review the Fed. Cir. panel below, 647 F.3d 1373 (Fed. Cir. 2011) in which the panel decision refused to reverse a district court decision that instructed the jury that it could … Continue reading →

Posted in Doctrine of Equivalents | Tagged biotechnology, biotechnology law, biotechnology news, doctrine of equivalents, DOE, Federal Circuit, intellectual property, ip, LSO crystals, Patent Law, patents, saint-gobain, siemens, Supreme Court, Warren Woessner | 1 Comment

Siemens v. Saint-Gobain – What’s Sauce For The Goose May Leave The Gander Unscathed

Posted on March 8, 2011 by Warren Woessner

Contributed by Jim Nelson, J.D., Ph.D. of Schwegman Lundberg & Woessner, P.A. The Siemens Medical Solutions USA, Inc. v. Saint-Gobain Ceramics & Plastics, Inc., (a copy is available at the end of this post) case presents a fundamental issue and … Continue reading →